38 related articles for article (PubMed ID: 24939418)
1. Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias.
Tobin LA; Robert C; Rapoport AP; Gojo I; Baer MR; Tomkinson AE; Rassool FV
Oncogene; 2013 Apr; 32(14):1784-93. PubMed ID: 22641215
[TBL] [Abstract][Full Text] [Related]
2. Multifaceted actions of 8-amino-adenosine kill BCR-ABL positive cells.
Pillai RN; Chen LS; Ayres ML; Nowak BJ; Thomas MW; Shpall EJ; Keating MJ; Gandhi V
Leuk Lymphoma; 2012 Oct; 53(10):2024-32. PubMed ID: 22448923
[TBL] [Abstract][Full Text] [Related]
3. Pilot study of bortezomib for patients with imatinib-refractory chronic myeloid leukemia in chronic or accelerated phase.
Santos FP; Kantarjian H; McConkey D; O'Brien S; Faderl S; Borthakur G; Ferrajoli A; Wright J; Cortes J
Clin Lymphoma Myeloma Leuk; 2011 Aug; 11(4):355-60. PubMed ID: 21816374
[TBL] [Abstract][Full Text] [Related]
4. Hydroxychavicol sensitizes imatinib-resistant chronic myelogenous leukemia cells to TRAIL-induced apoptosis by ROS-mediated IAP downregulation: Erratum.
Anticancer Drugs; 2024 Apr; 35(4):383. PubMed ID: 38451676
[No Abstract] [Full Text] [Related]
5. Total polysaccharide of Yupingfeng protects against bleomycin-induced pulmonary fibrosis via inhibiting transforming growth factor-β1-mediated type I collagen abnormal deposition in rats.
Xu L; Li LC; Zhao P; Qi LW; Li P; Gao J; Fei GH
J Pharm Pharmacol; 2014 Dec; 66(12):1786-95. PubMed ID: 25209833
[TBL] [Abstract][Full Text] [Related]
6. Perioperative nutritional support of patients undergoing pancreatic surgery in the age of ERAS.
Bozzetti F; Mariani L
Nutrition; 2014; 30(11-12):1267-71. PubMed ID: 24973198
[TBL] [Abstract][Full Text] [Related]
7. Reducing RIP140 expression in macrophage alters ATM infiltration, facilitates white adipose tissue browning, and prevents high-fat diet-induced insulin resistance.
Liu PS; Lin YW; Lee B; McCrady-Spitzer SK; Levine JA; Wei LN
Diabetes; 2014 Dec; 63(12):4021-31. PubMed ID: 24969109
[TBL] [Abstract][Full Text] [Related]
8. Targeting bcr-abl transcripts with siRNAs in an imatinib-resistant chronic myeloid leukemia patient: challenges and future directions.
Koldehoff M
Methods Mol Biol; 2015; 1218():277-92. PubMed ID: 25319658
[TBL] [Abstract][Full Text] [Related]
9. Factors contributing to the duration of untreated psychosis.
Apeldoorn SY; Sterk B; van den Heuvel ER; Schoevers RA; Islam MA; ; Bruggeman R; Cahn W; deHaan L; Kahn RS; Meijer CJ; Myin-Germeys I; van Os J; Wiersma D
Schizophr Res; 2014 Sep; 158(1-3):76-81. PubMed ID: 25043913
[TBL] [Abstract][Full Text] [Related]
10. CIP2A is overexpressed and involved in the pathogenesis of chronic myelocytic leukemia by interacting with breakpoint cluster region-Abelson leukemia virus.
Wang J; Huang T; Sun J; Yu Y; Liu Z; Li W; Jia J; Chen C
Med Oncol; 2014 Aug; 31(8):112. PubMed ID: 25023053
[TBL] [Abstract][Full Text] [Related]
11. Resolution of acute inflammation bridges the gap between innate and adaptive immunity.
Newson J; Stables M; Karra E; Arce-Vargas F; Quezada S; Motwani M; Mack M; Yona S; Audzevich T; Gilroy DW
Blood; 2014 Sep; 124(11):1748-64. PubMed ID: 25006125
[TBL] [Abstract][Full Text] [Related]
12. Cerebrovascular complications in patients with inflammatory bowel disease.
Cojocaru IM; Cojocaru M; Sapira V; Ionescu A; Tacu N
Rom J Intern Med; 2014; 52(1):39-44. PubMed ID: 25000677
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of RASSF1 promoter methylation in prostate cancer.
Daniunaite K; Jarmalaite S; Kalinauskaite N; Petroska D; Laurinavicius A; Lazutka JR; Jankevicius F
J Urol; 2014 Dec; 192(6):1849-55. PubMed ID: 24980613
[TBL] [Abstract][Full Text] [Related]
14. Does tadalafil prevent erectile dysfunction in patients undergoing radiation therapy for prostate cancer?
Incrocci L
Asian J Androl; 2014; 16(5):664-5. PubMed ID: 24969064
[TBL] [Abstract][Full Text] [Related]
15. Clinical research in a modern Chinese peritoneal dialysis center.
Dong J; Zhao MH
Perit Dial Int; 2014 Jun; 34 Suppl 2(Suppl 2):S49-54. PubMed ID: 24962963
[TBL] [Abstract][Full Text] [Related]
16. Severe hypouricemia: biochemical expression of asymptomatic xanthinuria.
Ducorps M; Hélie C; Mayaudon H; Bauduceau B
Clin Chem; 1995 Dec; 41(12 Pt 1):1789-90. PubMed ID: 7497632
[No Abstract] [Full Text] [Related]
17. Cellular and molecular alterations induced by low‑dose fisetin in human chronic myeloid leukemia cells.
Klimaszewska-Wiśniewska A; Grzanka D; Czajkowska P; Hałas-Wiśniewska M; Durślewicz J; Antosik P; Grzanka A; Gagat M
Int J Oncol; 2019 Dec; 55(6):1261-1274. PubMed ID: 31638196
[TBL] [Abstract][Full Text] [Related]
18. Gene Expression Analysis of the 26S Proteasome Subunit PSMB4 Reveals Significant Upregulation, Different Expression and Association with Proliferation in Human Pulmonary Neuroendocrine Tumours.
Mairinger FD; Walter RF; Theegarten D; Hager T; Vollbrecht C; Christoph DC; Worm K; Ting S; Werner R; Stamatis G; Mairinger T; Baba H; Zarogoulidis K; Huang H; Li Q; Tsakiridis K; Zarogoulidis P; Schmid KW; Wohlschlaeger J
J Cancer; 2014; 5(8):646-54. PubMed ID: 25157275
[TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide and bortezomib interact synergistically to induce apoptosis in chronic myelogenous leukemia cells resistant to imatinib mesylate through Bcr/Abl‑dependent mechanisms.
Xu W; Wei W; Yu Q; Wu C; Ye C; Wu Y; Yan H
Mol Med Rep; 2014 Sep; 10(3):1519-24. PubMed ID: 24939418
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
